Jerome Benedict Durso - 01 Oct 2021 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
President & CEO, Director
Signature
/s/ Mary J. Grendell, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Oct 2021
Net transactions value
-$4,399
Form type
4
Filing time
05 Oct 2021, 17:28:09 UTC
Previous filing
02 Jul 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $4,399 -289 -0.35% $15.22 81,564 01 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.